Transcranial magnetic stimulation (TMS) is a neurostimulation and neuromodulation technique that has provided over two decades of data in focal, non-invasive brain stimulation based on the principles of electromagnetic induction. Its minimal risk, excellent tolerability and increasingly sophisticated ability to interrogate neurophysiology and plasticity make it an enviable technology for use in pediatric research with future extension into therapeutic trials. While adult trials show promise in using TMS as a novel, non-invasive, non-pharmacologic diagnostic and therapeutic tool in a variety of nervous system disorders, its use in children is only just emerging. TMS represents an exciting advancement to better understand and improve outcomes from disorders of the developing brain. 
Principles of TMS
Transcranial magnetic stimulation has been used for nearly three decades as a focal, non-invasive technique allowing for neurostimulation and modulation of the nervous system. Detailed reviews of TMS neurophysiological principles and methodology are available elsewhere [1] . Briefly, based on the principle of electromagnetic induction, introduction of focused magnetic elds generates regional cortical electrical elds which, when of sufficient magnitude and density, can depolarize focal neuronal populations.
Measureable outputs are produced, typically a motor evoked potential (MEP) measured by electromyography in a muscle controlled by the region of motor cortex being stimulated.
TMS can be applied in a single pulse method with one stimulus occurring at a time or pairedpulse methods where a test stimulus is preceded by a conditioning stimulus, the strength of each and the interval between them dictating specific effects reflective of cortical physiology.
Single pulse methods can be used for a variety of neurophysiologic assessment purposes, of feedback loops and activity-dependent metaplasticity [2] . Interested readers should refer to excellent review articles on TMS principles, safety and ethical considerations in adults and children for further information on the basic principles of TMS [2] [3] [4] .
Safety and tolerability of TMS in children
Neurobiological effects
Reviews of TMS devices suggest that harm to brain tissue from single or paired pulses is extremely unlikely [5] . Peak magnetic field strengths are 1. 
Potential adverse events in TMS
After years of study and millions of cumulative stimulations in the pediatric population, it has been established that TMS is safe and well tolerated in children [5, 9, 10] . This safety data is further supported by the more than 10-fold greater experience in adult TMS research.
Basic principles of disease specific safety and tolerability can be extrapolated from similar diseases and disease models across adults and children, such as comparing evidence from adult stroke [11] [12] [13] [14] [15] [16] to children with perinatal stroke and hemiparetic cerebral palsy [17, 18] .
These conclusions are further supported
by animal studies [19] [20] [21] [22] [23] [24] [25] and published consensus guidelines [26] . [32] .
While the evidence is more limited, existing repetitive (rTMS) studies in children generally report no signi cant adverse events [10, [33] [34] [35] .
At the time of the most comprehensive review on childhood TMS safety [5] , which included publications up to 2001, there were no published rTMS studies in children. Since 2001 however, there have been multiple studies using rTMS in pediatric and young adult (<25 years) populations (see Table 1 of certain amplitude in a target muscle. Such motor thresholds (either at rest or with muscle activation) provide an individualized reference for setting additional stimulation parameters [1] .
Using such simple, single-pulse measures, seminal studies by Eyre and others have helped de ne the normal evolution of cortical motor pathways from birth through early development [59, 60] .
Motor thresholds appears to increase over the first 3 months of life [59] then remain high with children under 10 years having higher thresholds 9 that decrease to adult levels by mid-adolesence [61] . In children, as in adults, Translational Neuroscience during the first 2 years with increasing dominance of contralateral projections. The uncrossed corticospinal pathway is faster than the crossed pathway before 6 months of age [59] and its prevalence is higher in proximal versus distal muscles in most children before the age of 10 years [66] . Clinically, preservation of these ipsilateral pathways correlates with "mirror movements" in children with unilateral early injuries and other motor developmental disorders [4] and may be associated with worse motor function. Combined with animal studies [67] [68] [69] , these human TMS studies have formed the basis for developmental motor plasticity models following early brain injuries such as perinatal stroke that may define novel central therapeutic targets [70] .
Paired pulse: cortico-cortical connections and interhemispheric inhibition
Intracortical motor systems and their role in the maturation of motor task performance have been studied through two main paradigms in children; cortical silent periods and paired pulse methods [3] .
Single pulse stimulation of the motor cortex during active contralateral muscle contraction evokes a sustained decrease in muscle activity termed the silent period. Inhibitory interneurons within the motor cortex are thought to be responsible for this contralateral silent period (CSP) [9] . The duration of the CSP at a given stimulus intensity reflects the integrity and excitability of cortical inhibitory mechanisms, thought to be mediated by gamma-aminobutyric acid-B receptors [71] .
The ontogeny of the silent period may reflect maturation of cortical inhibitory interneurons in the developing brain [9] . However, the agerelated changes in CSP characteristics are not well established. Studies investigating the developmental trend in CSP in children between 6-15 years of age found that CSP duration ranged widely (between 3.5 and 207 ms) using similar stimulation techniques [61, 72] . Across both studies, a significant agerelated increase in duration was found in one study but not the other [61, 72] . Therefore, the simplicity of the CSP represents an appealing method to interrogate cortical inhibitory systems but its large variance and relatively uncharacterized nature in young children represent current barriers to understanding its utility.
Paired pulse methods have also assessed intra-cortical excitability and inhibition by delivering two stimuli in a condition-test paradigm with interstimulus intervals (ISI) varying from 1 to 70 ms [3] . The GABA A receptor mediated [73] short interval intracortical inhibition (SICI) paradigm is the most established method for the study of intracortical inhibition in adults and children. One study examined the maturation of intracortical inhibition in subjects ranging from 6-34 years of age [74] . Using a 2 ms inter-stimulus interval, the study demonstrated that SICI is nearly four times greater in adults than in children less than 10 years of age [74] . As decreased levels of SICI may be associated with increased practice-dependent plasticity [75] , some have suggested that decreased SICI may reflect the neurophysiological mechanisms responsible for increased neuroplasticity in children [3] .
Additional paired pulse protocols generated 
TMS in child's nervous system and neurodevelopmental disorders
Perinatal stroke and cerebral palsy
Perinatal stroke causes most hemiparetic cerebral palsy and is a leading cause of lifelong neurological disability [77, 78] . Thanks to modern neuroimaging, current de nitions include distinct perinatal stroke diseases with specific timing (prenatal versus neonatal), mechanisms (arterial versus venous), and locations (cortical versus subcortical) [78] .
The common occurrence of such discrete, well defined injuries in an otherwise healthy brain makes perinatal stroke an ideal human model for the study of developmental motor plasticity using TMS [79] . Elegant work in animals [69] has recently combined with human TMS and imaging studies [80, 81] to generate working models of developmental motor plasticity following perinatal stroke.
This exciting progress has generated not only an increased understanding of disease-specific neurophysiology but has identified real central therapeutic targets and possible means by which they might be affected [70] .
The value of understanding neuroplasticity is only realized upon translation into improved patient outcomes [82] . In adults, the effects of anticonvulsant drugs on di erent parameters of cortical excitability have shed light on mechanisms of action and toxicity [73, [97] [98] [99] . TMS measures of cortical excitability may be able to predict responsiveness to anticonvulsants [100] or even the ketogenic diet [101] . In general, the findings of these studies have been consistent Table 2 highlights some recent advances in TMS epilepsy research.
The direct therapeutic potential of TMS in epilepsy remains undetermined. A series of five epilepsy patients who experienced in-session seizures during low frequency rTMS over their seizure focus suggests caution is required (see Table 2 , Rotenberg et al.) [102] . A small study applying different frequencies of rTMS in 7 adults with epilepsia partialis continua suggested favourable safety and possible transient effects [49] . A randomized, 
Depression
Major depression is a major public health problem and affects approximately 15% of adolescents [105] . It is associated with impairment in social, family, and academic functioning, and it is a major risk factor for suicide -a leading cause of death in teenagers [106, 107] . Treatments are limited with the one class of approved medications and cognitive behavioural therapy having combined remission rates of only 30-45% [108] . There is overwhelming evidence that additional treatment options are urgently needed to improve outcomes for teens with depression.
One novel treatment for adolescent major depressive disorder (MDD) is rTMS whose therapeutic potential is increasingly established in adult depression [109] . The majority of adult studies have targeted the dominant dorsolateral prefrontal cortex (DLPFC) though precise mechanisms of action are not well understood. In the adult literature, over 1,300 MDD subjects have been treated safely with rTMS [109, 110] . Studies in children have been limited with only 23 total published cases to date [41, 52, 56] . This is surprising given the urgent need mentioned above, reluctance of young depression patients to take medication, and evidence suggesting younger adults with depression respond better to rTMS [111, 112] .
Some illustrative studies of TMS in depression of adolescents and young adults are described in Table 3 .
Multiple cautionary issues were identified in a 2008 [52] study described in Table 3 One patient experienced a reduction in EPC with remission by 24 hours that lasted for two weeks. The other patient showed only a minimal improvement with a decrease in frequency of EEG spikes. The authors concluded that a single rTMS session could reduce focal epileptogenic activity and should be explored as an alternative approach for resistant, continuous seizures Table 2 . TMS studies in epilepsy subjects.
TMS-evoked SICI correlates with both ADHD severity and motor skill development [114] .
A proposed mechanism suggests that the surround inhibition produced by GABAergic interneurons and modulated by dopamine may be important for refining cortical signals involved in the accurate selection and control of motor responses in ADHD [115] .
Disturbed transcallosal motor inhibition in children with ADHD has also been evaluated.
Buchmann et al. [116] used TMS to explore motor cortex and corpus callosum physiology in 13 children with ADHD compared to controls. 
Tourette syndrome (TS)
Tourette syndrome is another example of a common childhood neurodevelopmental disorder with complex, poorly understood neurobiology. Table 4 illustrates some of the pioneering childhood and young adult studies of TMS in Tourette syndrome.
Other potential neuropsychiatric applications One patient stopped treatment early due to anxiety and mood lability, 1 had hypomania and 1 attempted suicide 3 weeks after rTMS.
Mayer
Improvements in depressive symptoms and cognitive functioning immediately which persisted at long-term (3 years) follow-up. Limitations: small sample size, lack of controls and a heterogeneous sample (some received ECT and medications in addition to rTMS).
Wall 2011 [41] 8 adolescents
Open label -subjects maintained on a stable dose of selective serotonin reuptake inhibitor (SSRI). Treated with 30 sessions of 10 Hz TMS at 120% motor threshold applied to the DLPFC.
One adolescent dropped out due to poor tolerance. Depression improved significantly from baseline over the 30 treatments and persisted at 6 month follow-up. There was no neurocognitive decline in function compared to baseline.
of therapeutic effect. Numerous issues in neuropsychiatry potentially amenable to TMS applications await further exploration in young adults and children.
Headache
Headache is the leading cause of both recurrent and chronic pain in children [128] . been extensively examined in adult migraine [129] . Preliminary studies have begun to explore PT in children with migraine [130] .
A small study of children aged 8-18 years received TMS to study regional excitability of the occipital lobe (PT) as well as motor cortex (resting motor threshold, cortical silent period).
Ten children with migraine without aura were compared to age-matched healthy controls 
Traumatic brain injury / concussion
By the age of ten, over 1 in 10 children will sustain a mild traumatic brain injury/ concussion and 1 in 7 school children will suffer post-concussion syndrome (PCS) [132] .
PCS is a constellation of clinical symptoms including physical (i.e. headaches), cognitive sparing of sensory systems [134] . A study of 9 collegiate athletes examined acutely (<24 hrs) after a concussion [135] found suggested changes in MEPs persisting up to 10 days after injury.
Recent adult reviews suggest a potential for non-invasive brain stimulation to understand and enhance neuroplasticity following traumatic brain injury (TBI) [132, 133, 136] .
A study examining 17 patients with severe TBI and diffuse axonal brain injury showed higher overall motor thresholds, smaller MEP area under the curve values, and narrower recruitment curves [137] . The authors suggested impairment of both excitatory and inhibitory motor cortex systems may occur but do not proceed in parallel, instead demonstrating distinct patterns across different degrees of TBI.
The ability of TMS to improve deficits such as hand motor function and mood disorders that occur frequently in TBI suggest it might also be considered as a therapeutic modality. With such diverse dysfunction, targets might include emerging rTMS targets such as visuospatial and language dysfunction, working memory and executive function, spasticity, pain and gait abnormalities [133] . These approaches await exploration in the pediatric population. achieved [143] . TMS may also prove useful in the preoperative mapping of cerebrovascular anomalies that may impair the quality of data collected using fMRI through hemodynamic artifacts [144] . While navigated TMS has been used in adults for preoperative mapping of central cortical regions with data showing good correlation to fMRI in detecting central motor cortex [145] , this case suggests it may also be feasible in young children.
Pre-neurosurgical evaluation

Transcranial direct current stimulation in children
Transcranial direct current stimulation (TDCS)
is a non-invasive brain stimulation tool that can modulate brain activity via weak electrical currents applied to the scalp through placement of an anode and a cathode. This modality is being transitioned from the adult research world into pediatrics including the study of epilepsy [146, 147] , dystonia [148] , and headache [149] .
A recent study in children suggests that cathodal TDCS, which typically is thought to suppress regional cortical excitability, showed some mild decreases in focal seizure activity and electrical EEG activity for 48 hours in a population of 36 children aged 6-15 years who received a single treatment with 1 mA cathodal TDCS for 20 min with the cathode positioned over the seizure focus and anode on the contralateral shoulder [146] . However, in a small series of 5 children who received cathodal TDCS for refractory continuous spike wave in sleep epilepsy, the TDCS did not reduce the frequency of continuous epileptiform activity in any of the patients [147] . Thus, the use of TDCS requires further examination in the developing epilepsy population.
In childhood dystonia, inhibitory cathodal TDCS was hypothesized to reduce increased motor cortex excitability and was applied to 10 children with dystonia. Four patients showed improvements in either involuntary overflow activity and/or muscle control [148] .
Finally, a recent subpopulation of 44 adolescents who received TDCS with chronic post-traumatic headaches after mild head injury showed improvements in their symptoms equivalent to current available pharmacologic therapies, the effects of which lasted 5-9 months with good tolerance of the TDCS procedure [149] . It was noted that the effectiveness depended on the localization of stimulating electrodes used for different types of headaches studied, providing avenues for ongoing research in the area of headache treatment.
In general, it appears that TDCS is well tolerated in the children studied in the emerging literature, however more research is required to truly establish its safety and efficacy in the pediatric population. 
Controversial applications of TMS
